Boothbay Fund Management’s Haemonetics HAE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $213K | Sell |
2,852
-5,811
| -67% | -$434K | ﹤0.01% | 1036 |
|
|
2025
Q1 | $551K | Buy |
+8,663
| New | +$551K | 0.01% | 677 |
|
|
2024
Q3 | – | Sell |
-28,179
| Closed | -$2.33M | – | 1538 |
|
|
2024
Q2 | $2.33M | Buy |
28,179
+12,881
| +84% | +$1.07M | 0.06% | 375 |
|
|
2024
Q1 | $1.31M | Buy |
+15,298
| New | +$1.31M | 0.03% | 557 |
|
|
2023
Q2 | – | Sell |
-2,740
| Closed | -$227K | – | 1751 |
|
|
2023
Q1 | $227K | Buy |
2,740
+152
| +6% | +$12.6K | ﹤0.01% | 1442 |
|
|
2022
Q4 | $204K | Buy |
+2,588
| New | +$204K | ﹤0.01% | 1369 |
|
|
2021
Q3 | – | Sell |
-18,604
| Closed | -$1.24M | – | 1774 |
|
|
2021
Q2 | $1.24M | Buy |
18,604
+16,032
| +623% | +$1.07M | 0.04% | 513 |
|
|
2021
Q1 | $286K | Buy |
+2,572
| New | +$286K | 0.01% | 996 |
|